Meiling Chu
725 South Wanping Road
Shanghai, 200032, China
Shanghai, 200032, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
PD-1 blockade elicits a systemic immune response but not in the tumor of TNBC mice.
Journal: Acta biochimica et biophysica Sinica
Published: February 04, 2026
Effects of the efficacy of the Yi Shen Tiao Gan formula on aromatase inhibitor associated musculoskeletal syndrome: a randomized controlled trial.
Journal: Frontiers in pharmacology
Published: June 03, 2025
SOCS3: An Immunological Biomarker Offering Potential Therapeutic Targets for Malignant Tumors.
Journal: Biological procedures online
Published: April 13, 2025
Yi Shen Tiao Gan decoction alleviates aromatase inhibitor-related bone loss by promoting H-type vessel formation.
Journal: Translational oncology
Published: August 31, 2024
Breast Cancer Bone Metastasis: Novel Prognostic Biomarkers Identified.
Journal: Phenomics (Cham, Switzerland)
Published: March 22, 2024
Molecular mechanism of Ruxian Shuhou prescription in the treatment of triple-negative breast cancer based on network pharmacology.
Journal: Medicine
Published: September 01, 2023
Construction and validation of a risk prediction model for aromatase inhibitor-associated bone loss.
Construction and validation of a risk prediction model for aromatase inhibitor-associated bone loss.
Journal: Frontiers in oncology
Published: March 09, 2023
Association between endocrine therapy and cognitive decline in breast cancer based on propensity score matching.
Journal: Frontiers in medicine
Published: December 27, 2022
Showing 1-8 of 8
Last Updated: 09/26/2026